# Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients

> **NCT01436539** · PHASE4 · UNKNOWN · sponsor: **Jun Cheng** · enrollment: 300 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Adefovir Dipivoxil and polyene phosphatidylcholine
- **DRUG:** Adefovir Dipivoxil

## Key facts

- **NCT ID:** NCT01436539
- **Lead sponsor:** Jun Cheng
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2013-03
- **Final completion:** 2013-07
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2011-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01436539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01436539, "Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT01436539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*